CNBX Pharmaceuticals's total assets for Q3 2025 were $18.61K, a decrease of -63.26% from the previous quarter. CNBX total liabilities were $2.56M for the fiscal quarter, a -2.48% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.